| pubmed-article:20478057 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C0087071 | lld:lifeskim |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C1709323 | lld:lifeskim |
| pubmed-article:20478057 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:20478057 | pubmed:dateCreated | 2010-6-9 | lld:pubmed |
| pubmed-article:20478057 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:abstractText | The sole effective option for patients with advanced HCC is sorafenib and there is an urgent need to develop new therapeutic approaches. Immunotherapy is a promising option that deserves major investigation. In this open label, single arm clinical trial, we analyzed the effect of a low dose cyclophosphamide treatment in combination with a telomerase peptide (GV1001) vaccination in patients with advanced HCC. | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20478057 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20478057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20478057 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20478057 | pubmed:issn | 1471-2407 | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:MannsMichael... | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:BruixJordiJ | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:GretenTim FTF | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:AyusoCarmenC | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:BeaugrandMich... | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:KorangyFirouz... | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:BargetNathali... | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:OrmandyLars... | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:FornerAlejand... | lld:pubmed |
| pubmed-article:20478057 | pubmed:author | pubmed-author:N'KontchouGis... | lld:pubmed |
| pubmed-article:20478057 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20478057 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:20478057 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20478057 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20478057 | pubmed:pagination | 209 | lld:pubmed |
| pubmed-article:20478057 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:meshHeading | pubmed-meshheading:20478057... | lld:pubmed |
| pubmed-article:20478057 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20478057 | pubmed:articleTitle | A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma. | lld:pubmed |
| pubmed-article:20478057 | pubmed:affiliation | Department of Gastroenterology, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany. tim.greten@nih.gov | lld:pubmed |
| pubmed-article:20478057 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20478057 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20478057 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:20478057 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
